Precigen News and Activities

Presence

Precigen is a biotechnology company that develops gene and cell therapies, immunotherapy products, and related biomanufacturing services for patients, healthcare providers, and research partners in serious diseases.

Precigen products and services overview:

Gene therapies
Cell therapies
Cancer immunotherapy
Vaccine platforms
Biomanufacturing services

Revenue: ~$4 million

Employees: 150

Headquarters: Germantown, United States (USA)

Precigen is one of the...

Precigen is a company listed under the stock ticker PGEN (US).

Precigen has a direct presence in 4 countries.

Precigen has 6 subsidiaries including Aqua Bounty Technologies, Okanagan Specialty Fruits and Oxitec.

They are in:

Biotechnology86%
Food14%

Executives

View the org chart displaying its 78 main executives

Most searched biographies at Precigen

Create your alert
to follow the executive moves at Precigen.

Biotechnology

Precigen has 2,415 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

RQ Biotechnology has just announced a $86 Million fundraising (posted on June 24 2026).
Boundless Bio has filed its IPO. Its stock ticker will be AATD. (posted on June 23 2026).
Boundless Bio will change its company name to Serapha Bio on Dec 31, 2026. (posted on June 23 2026).